Mylan Gets OK To Sell Generic Insomnia Drug During IP Fight
A London judge on Wednesday rejected Neurim Pharmaceuticals' bid to delay a generic version of its insomnia medication made by Mylan UK from hitting the market, saying the patent holder could...To view the full article, register now.
Already a subscriber? Click here to view full article